Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Cork
Clinical trial register · Ireland

Clinical Trials in Cork, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Ireland and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Alert me on this filter Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 607 matching records held by the registry are in this view. Synced 21 Nov 2026, 03:15 UTC
607
Studies in scope
all four open statuses
303
Recruiting now
open to new participants
167
Lead sponsors
across recruiting studies
35
Irish site locations
across all listed studies
Phase mix of the 303 recruiting studies
Phase 3 92 Not applicable 75 Observational 71 Phase 2 25 Phase 1/2 21 Other 19

Trials with a site in Cork

169 of 607 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Irish sites
Start
Not yet open
Boehringer Ingelheim
Phase 3
1,500
Cork, Dublin
2027-01-11
Recruiting
Hoffmann-La Roche
Phase 2
474
Cork
2026-11-11
Not yet open
Effects of a Botanical Extract on Cognitive Performance and Cerebral Blood Flow in Healthy Adults
NCT07939334 Cognitive Change, Cerebral Blood Flow, Memory, Stress (Psychology)
Finzelberg GmbH & Co. KG
Not applicable
78
Cork
2026-11
Recruiting
Newborn Brain Assessment - CergenX Wave
NCT07857070 Neonatal Encephalopathy, Neonatal Encephalopathy (Neonatal Hypoxic-ischemic Encephalopathy), Neonatal Encephalopathy, Unspecified
CergenX Limited
Observational
165
Cork
2026-10-22
Not yet open
Patient-Initiated Follow-Up for Women After Early Breast Cancer Treatment (LYSA2PIFU)
NCT07840534 Breast Cancer, Breast Cancer Survivorship, Cancer Survivorship, Endocrine Therapy
University College Cork
Not applicable
30
Cork
2026-10-01
Recruiting
Takeda
Phase 3
324
Cork, Dublin, Galway
2026-09-10
Recruiting
Optimising Adjuvant Chemotherapy Prescription in Young Patients With Hormone-dependent Breast Cancer Using Genomic Tests
NCT07106632 Early Breast Cancer, Premenopausal Breast Cancer, HR+/HER2- Breast Cancer
UNICANCER
Phase 3
3,380
Cork, Dublin, Limerick, Tullamore, Waterford
2026-06-26
Recruiting
INSPIRE: INnovative SABR for Prostate Cancer All IREland
NCT07552168 Prostate Adenocarcinoma
Cancer Trials Ireland
Phase 2
136
Dublin, Cork, Waterford
2026-04-23
Recruiting
K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
Phase 3
420
Cork, Dublin
2026-04-17
Recruiting
Boehringer Ingelheim
Phase 3
670
Cork
2026-04-13
By invitation
Intelligent Physiological Monitoring to Predict Preterm Brain Injury
NCT07880431 Cerebral Palsy (CP), Intraventricular Hemorrhage Neonatal, Periventricular Leukomalacia, Neurodevelopmental Delay
University College Cork
Observational
413
Cork
2026-04-13
Recruiting
Generating Intervals of Reference FFor Early Life Brain Biomarkers.
NCT07585149 Reference Intervals, Biomarker in Early Diagnosis, Neonatal
University College Cork
Observational
150
Cork
2026-04-13
Recruiting
CP: Intestinal Permeability
NCT07586930 Intestinal Permability
Rousselot BVBA
Not applicable
92
Cork
2026-03-25
Recruiting
Chr Hansen - part of Novonesis
Not applicable
90
Cork
2026-03-18
Recruiting
Merck Sharp & Dohme LLC
Phase 3
900
Cork, Dublin
2026-02-16
Not yet open
University College Cork
Not applicable
200
Cork
2026-02
Active, closed
CSL Behring
Phase 2
84
Cork, Dublin
2026-01-22
Recruiting
University Hospital, Basel, Switzerland
Not applicable
1,060
Cork, Dublin, Galway
2026-01-01
Recruiting
Eli Lilly and Company
Phase 3
800
Cork, Dublin, Galway
2025-12-22
Recruiting
Amazentis SA
Not applicable
120
Cork
2025-12-10
Recruiting
Merck Sharp & Dohme LLC
Phase 3
904
Cork, Dublin
2025-11-26
Recruiting
Cancer Trials Ireland
Not applicable
1,600
Dublin, Cork, Galway
2025-11-11
Recruiting
University of Dublin, Trinity College
Observational
380
Cork, Dublin
2025-10-01
Recruiting
Vertex Pharmaceuticals Incorporated
Phase 2/3
176
Cork, Dublin, Galway
2025-09-30
Recruiting
Boston Scientific Corporation
Not applicable
1,616
Cork, Dublin, Galway
2025-08-21
Recruiting
The Satiety Control Optimization by Nutritional Enhancement Study
NCT07420023 Metabolic Diseases, Type 2 Diabetes, Cardiovascular Disease
University College Cork
Not applicable
24
Cork
2025-08-18
Recruiting
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
227
Cork, Dublin, Galway
2025-08-05
Recruiting
Kerry Group P.L.C
Not applicable
160
Cork
2025-07-15
Active, closed
DBV Technologies
Phase 3
480
Cork, Dublin
2025-06-24
Recruiting
GlaxoSmithKline
Phase 3
981
Dublin, Cork, Drogheda, Galway, Mullingar
2025-06-20
Recruiting
Boehringer Ingelheim
Phase 3
1,755
Cork, Dublin
2025-06-09
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,440
Dublin, Cork
2025-05-13
Recruiting
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
NCT06881784 NSCLC (Non-small Cell Lung Cancer), Non-Small Cell Lung Cancer, NSCLC, NSCLC (Non-small Cell Lung Carcinoma)
Revolution Medicines, Inc.
Phase 3
590
Cork, Dublin, Galway
2025-05-06
Recruiting
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
448
Cork, Dublin, Galway, Waterford
2025-05-05
Recruiting
Single vs. Multiple Fraction Trial of Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastases/Progression
NCT05784428 Oligometastatic Disease, Oligoprogression, Toxicity Due to Radiotherapy, Quality of Life
Robert Olson
Not applicable
598
Galway, Dublin, Cork, Waterford
2025-04-16
Recruiting
University Health Network, Toronto
Observational
3,000
Castlebar, Cork, Dublin, Galway, Waterford
2025-04-14
Recruiting
AstraZeneca
Phase 3
830
Cork, Dublin, Galway
2025-04-10
Recruiting
Assessing Intellectual and Motor Outcomes in High-risk Infants
NCT06857539 Cerebral Palsy, Cerebral Palsy (CP), Cerebral Palsy Children, High-risk Infants
University College Cork
Observational
600
Cork, Dublin
2025-03-21
Recruiting
AbbVie
Observational
1,200
Dublin, Elm Park, Tralee, Cork
2025-01-31
Recruiting
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
NCT06788990 Metastatic Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma
Bicara Therapeutics
Phase 2/3
650
Cork, Dublin
2025-01-28
Active, closed
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain
NCT06500455 Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Metastatic Digestive System Carcinoma, Metastatic Lung Non-Small Cell Carcinoma
NRG Oncology
Phase 3
274
Dublin, Galway, Cork
2024-12-12
Active, closed
Genmab
Phase 3
191
Dublin, Cork, Limerick, Waterford
2024-11-25
Recruiting
University College Cork
Observational
300
Cork
2024-11-04
Recruiting
Microbiome Immunotherapy Neoadjuvant Assessment
NCT06709651 Triple Negative Breast Cancer
University College Cork
Observational
30
Cork
2024-10-02
Active, closed
Pendulum Therapeutics
Not applicable
30
Cork
2024-09-23
Recruiting
Regeneron Pharmaceuticals
Phase 2
116
Galway, Cork, Dublin
2024-09-16
Active, closed
Alpine Immune Sciences Inc, A Subsidiary of Vertex
Phase 3
605
Cork, Dublin, Galway, Waterford
2024-08-30
Active, closed
AbbVie
Phase 3
1,400
Drogheda, Cork, Dublin
2024-06-27
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,530
Cork, Dublin, Galway
2024-06-24
Recruiting
University College Cork
Not applicable
70
Cork
2024-05-16
Recruiting
Janssen Research & Development, LLC
Phase 3
641
Cork, Dublin
2024-04-18
Recruiting
Daiichi Sankyo
Phase 1/2
680
Dublin, Cork, Galway
2024-04-10
Recruiting
University College Cork
Not applicable
150
Cork
2024-03-28
Recruiting
Italfarmaco
Phase 3
220
Cork, Dublin
2024-03-26
Recruiting
A Phase 1/2 Study of IAM1363 in HER2 Cancers
NCT06253871 HER2 Mutation-Related Tumors, HER2, HER2-positive Breast Cancer, HER2 + Breast Cancer
Iambic Therapeutics, Inc
Phase 1/2
463
Dublin, Cork
2024-03-25
By invitation
School-aged Outcomes Post Hypoxic Ischaemic Encephalopathy
NCT07770035 Hypoxic-Ischemic Encephalopathy
University College Cork
Observational
196
Cork
2024-03-09
Recruiting
University College Cork
Not applicable
40
Cork
2024-02-14
Active, closed
Assessment of Diastolic Function During the Transitional Period and Infancy Using Serial Echocardiography
NCT06200519 Diastolic Dysfunction, Neonatal Encephalopathy, Small for Gestational Age at Delivery, Transient Tachypnea of the Newborn
University College Cork
Observational
216
Cork
2024-02-12
Recruiting
Janssen-Cilag Ltd.
Observational
900
Cork, Dublin, Galway
2023-12-18
Active, closed
Merck Sharp & Dohme LLC
Phase 3
710
Cork, Dublin
2023-12-06
Active, closed
UNEEG Medical A/S
Not applicable
19
Cork, Dublin
2023-12-04
Recruiting
Cancer Trials Ireland
Phase 1/2
126
Cork, Dublin
2023-11-21
Not yet open
University of Dublin, Trinity College
Phase 3
952
Cork, Dublin, Galway
2023-11
Active, closed
Cancer Trials Ireland
Phase 2
11
Galway, Dublin, Cork, Limerick
2023-10-26
Active, closed
AstraZeneca
Phase 3
5,511
Cork, Dublin, Galway, Waterford
2023-10-05
Recruiting
Discontinuation Study
NCT05866757 Multiple Myeloma, Cancer, Hematologic Cancer
University College Cork
Not applicable
70
Cork
2023-08-28
Recruiting
Early Detection & Intervention of Cerebral Palsy in Ireland
NCT05907837 Cerebral Palsy, Neurodevelopmental Disorders
University College Cork
Observational
1,500
Cork, Dublin, Limerick
2023-07-01
Active, closed
Alfasigma S.p.A.
Observational
509
Cork, Dublin
2023-06-12
Active, closed
Linking In With Advice and Supports for Men Impacted by Metastatic Cancer
NCT05946993 Survivorship, Prostate Cancer, Kidney Cancer, Urothelial Tract/Bladder Cancer, Nos
University College Cork
Not applicable
72
Cork
2023-05-08
Active, closed
Servier Affaires Médicales
Phase 3
299
Cork, Dublin
2023-05-03
Active, closed
Ultimaster Nagomi™ Sirolimus Eluting Coronary Stent System in Complex PCI Patients
NCT05705973 Cardiovascular Disease, Coronary Artery Occlusion, Ischemic Heart Disease
Terumo Europe N.V.
Observational
3,000
Cork, Dublin, Galway
2023-04-25
Active, closed
Karyopharm Therapeutics Inc
Phase 3
257
Dublin, Cork, Galway, Waterford
2023-04-18
Active, closed
AbbVie
Phase 3
520
Dublin, Cork, Galway, Sligo, Waterford
2023-03-15
Active, closed
DBV Technologies
Phase 3
600
Cork, Dublin
2023-02-21
Recruiting
Dopamine vs. Norepinephrine for Hypotension in Very Preterm Infants With Late-onset Sepsis
NCT05347238 Late-Onset Neonatal Sepsis, Extreme Prematurity, Neonatal Hypotension
Mount Sinai Hospital, Canada
Observational
550
Cork
2023-02-06
Active, closed
Bristol-Myers Squibb
Phase 3
516
Manorhamilton, Cork, Dublin
2023-01-12
Active, closed
Incyte Corporation
Phase 3
82
Cork, Dublin, Galway
2022-12-23
Active, closed
Vertex Pharmaceuticals Incorporated
Phase 3
822
Cork, Dublin, Limerick
2022-11-08
Active, closed
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
325
Cork, Dublin, Waterford
2022-10-24
Active, closed
A Study to Learn More About How Well Elinzanetant Works and How Safe it is Compared to Placebo for the Treatment of Hot Flashes Caused by Anti-cancer Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast Cancer
NCT05587296 Vasomotor Symptoms Caused by Adjuvant Endocrine Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast Cancer, Hot Flashes
Bayer
Phase 3
474
Galway, Dublin, Cork, Waterford
2022-10-14
Active, closed
Eli Lilly and Company
Phase 3
8,000
Cork, Dublin, Galway, Sligo, Waterford
2022-10-04
Recruiting
Stereotactic Ablative Radiotherapy for OligoMetastatic Breast Cancer
NCT05377047 Breast Cancer Stage IV, Oligometastatic Disease
Vastra Gotaland Region
Phase 3
345
Cork, Dublin, Galway
2022-09-19
Recruiting
Institute of Cancer Research, United Kingdom
Phase 3
1,128
Cork, Dublin, Limerick
2022-09-09
Active, closed
Novo Nordisk A/S
Phase 3
412
Cork, Dublin
2022-08-10
Active, closed
Cogent Biosciences, Inc.
Phase 2
237
Cork, Dublin
2022-06-27
Active, closed
30% or 60% Oxygen at Birth to Improve Neurodevelopmental Outcomes in Very Low Birthweight Infants
NCT03825835 Premature Infant, Respiratory Distress Syndrome in Premature Infant, Neurodevelopmental Outcome
University of Alberta
Not applicable
1,203
Cork
2022-06-27
Active, closed
Boston Scientific Corporation
Not applicable
500
Cork
2021-12-21
Active, closed
Cancer Trials Ireland
Phase 1
16
Cork, Dublin, Galway
2021-12-08
Recruiting
Blueprint Medicines Corporation
Phase 2/3
534
Cork
2021-11-30
Active, closed
Daiichi Sankyo
Phase 3
490
Cork, Dublin
2021-05-21
Active, closed
German CLL Study Group
Phase 3
897
Cork, Dublin, Galway, Limerick, Waterford
2021-03-01
Active, closed
Celgene
Phase 3
313
Cork, Dublin
2021-02-25
Active, closed
iCorMicA - Stratified Medicine in Angina
NCT04674449 Microvascular Angina, Angina, Stable, Ischemia With No Obstructive Coronary Arteries (INOCA), Coronary Microvascular Dysfunction (CMD)
NHS Greater Glasgow and Clyde
Not applicable
1,000
Cork, Dublin
2020-12-30
Active, closed
Amgen
Phase 3
135
Cork
2020-12-04
Active, closed
Daiichi Sankyo
Phase 3
1,600
Dublin, Cork, Limerick
2020-12-04
Recruiting
Mirati Therapeutics Inc.
Phase 2/3
626
Cork, Dublin, Galway, Limerick, Waterford
2020-12-02
Recruiting
ErythroPOietin Alfa to Prevent Mortality and Reduce Severe Disability in Critically Ill TRAUMA Patients
NCT04588311 Trauma, Traumatic Injury, Traumatic Brain Injury, Wounds and Injuries
Australian and New Zealand Intensive Care Research Centre
Phase 3
2,500
Beaumont, Cork, Dublin
2020-11-09
Active, closed
Sacituzumab Govitecan in Primary HER2-negative Breast Cancer
NCT04595565 HER2-negative Breast Cancer, Triple Negative Breast Cancer
GBG Forschungs GmbH
Phase 3
1,332
Cork, Dublin, Limerick, Waterford
2020-10-28
Active, closed
Using FDG-PET/CT to Assess Response of Bone-Dominant Metastatic Breast Cancer, FEATURE Study
NCT04316117 Anatomic Stage IV Breast Cancer AJCC v8, Hormone Receptor Positive Breast Carcinoma, Metastatic Breast Carcinoma, Prognostic Stage IV Breast Cancer AJCC v8
ECOG-ACRIN Cancer Research Group
Phase 2
138
Cork
2020-09-15
Active, closed
University of Sydney
Phase 3
1,100
Rathgar, Cork, Dublin, Galway
2020-03-31
Recruiting
TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention
NCT04294927 BRCA1 Gene Mutation, BRCA2 Gene Mutation, RAD51C Gene Mutation, RAD51D Gene Mutation
University Medical Center Nijmegen
Not applicable
8,380
Cork
2020-03-01
Active, closed
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
777
Cork, Dublin, Galway, Limerick
2019-12-20
Recruiting
Melanoma and Skin Cancer Trials Limited
Not applicable
2,998
Cork, Dublin
2019-12-17
Active, closed
British Columbia Cancer Agency
Not applicable
330
Rathgar, Dublin, Cork
2019-11-01
Active, closed
Letrozole With or Without Paclitaxel and Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
NCT04095364 Low Grade Fallopian Tube Serous Adenocarcinoma, Ovarian Low Grade Serous Adenocarcinoma, Primary Peritoneal Low Grade Serous Adenocarcinoma, Stage II Fallopian Tube Cancer AJCC v8
NRG Oncology
Phase 3
450
Cork, Dublin
2019-09-20
Active, closed
Regeneron Pharmaceuticals
Phase 3
415
Dublin, Cork, Galway
2019-06-04
Active, closed
A Clinical Efficacy and Safety Study of OHB-607 in Preventing Bronchopulmonary Dysplasia in Extremely Premature Infants
NCT03253263 Bronchopulmonary Dysplasia, Chronic Lung Disease of Prematurity, Intraventricular Hemorrhage, Retinopathy of Prematurity (ROP)
OHB Neonatology Ltd.
Phase 2
295
Cork
2019-05-09
Active, closed
Institut de Recherches Internationales Servier
Phase 3
856
Cork, Dublin
2019-03-21
Active, closed
Hoffmann-La Roche
Phase 3
927
Cork, Dublin
2018-05-28
Active, closed
pharmaand GmbH
Phase 3
1,097
Cork, Limerick, Waterford
2018-05-14
Active, closed
AstraZeneca
Phase 2
273
Cork, Dublin
2018-03-07
Active, closed
DePuy Orthopaedics
Not applicable
400
Cork
2017-09-19
Active, closed
DePuy Orthopaedics
Not applicable
400
Cork
2017-05-30
Active, closed
AbbVie
Phase 3
950
Dublin, Elm Park, Cork, Galway
2017-01-31
Active, closed
DBV Technologies
Phase 3
300
Cork, Dublin
2017-01-23
Active, closed
Eisai Inc.
Phase 3
1,069
Cork, Dublin, Galway
2016-10-13
Active, closed
DePuy Orthopaedics
Not applicable
540
Cork
2016-09-01
Recruiting
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
NCT02735707 Respiratory Tract Diseases, Influenza (Pandemic), Influenza, Community Acquired Pneumonia
UMC Utrecht
Phase 3
20,000
Cork, Dublin, Galway, Waterford
2016-04-11
Active, closed
Phase III Radium 223 mCRPC-PEACE III
NCT02194842 Prostate Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
446
Cork, Dublin
2015-10
Active, closed
University College, London
Phase 3
11,000
Cork, Dublin, Galway, Limerick, Sligo, Waterford
2015-10
Active, closed
Alliance Foundation Trials, LLC.
Phase 3
5,796
Cork, Dublin, Limerick, Sligo, Waterford
2015-08
Active, closed
University of Sydney
Phase 3
802
Cork, Galway, Dublin
2014-03
Active, closed
TAILORx Tissue Bank
NCT02050750 Breast Cancer
Cancer Trials Ireland
Observational
600
Cork, Donegal, Dublin, Galway, Limerick, Sligo, Waterford
2013-12
Active, closed
UNICANCER
Phase 3
1,173
Cork, Dublin, Galway
2013-11-13
Recruiting
Breast Cancer Proteomics and Molecular Heterogeneity
NCT01840293 Primary Breast Cancer, Recurrent/Metastatic Breast Cancer
Cancer Trials Ireland
Observational
1,780
Cork, Dublin, Limerick, Waterford
2013-02
Active, closed
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
NCT01272037 Breast Ductal Carcinoma In Situ, Invasive Breast Carcinoma, Multicentric Breast Carcinoma, Multifocal Breast Carcinoma
National Cancer Institute (NCI)
Phase 3
5,018
Cork, Dublin, Mount Merrion, Galway, Limerick, Sligo, Waterford, Letterkenny
2011-02-28
Active, closed
European Organisation for Research and Treatment of Cancer - EORTC
Observational
200
Cork, Dublin, Waterford
2010-12
Active, closed
Cancer Trials Ireland
Phase 2
251
Cork, Dublin
2009-07-20
Active, closed
Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
NCT00310180 Breast Adenocarcinoma, Hormone Receptor Positive, Stage IA Breast Cancer AJCC v7, Stage IB Breast Cancer AJCC v7
National Cancer Institute (NCI)
Phase 3
10,273
Cork, Dublin, Mount Merrion, Galway, Limerick, Sligo, Waterford, Letterkenny
2006-04-07
Rows per page Showing 1–169 of 169
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Irish investigative site, filtered. Derived from ClinicalTrials.gov, U.S. National Library of Medicine. Retrieved 21 November 2026. https://priyalifescience.com/clinical-trials-ireland/city/cork

Query this register directly
GET /api/trials?country=ie&status=recruiting&phase=Phase+3&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Ireland and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 607 studies in total at the last sync on 21 Nov 2026, 03:15 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 169 of those studies with a site in Cork.

How many clinical trials are recruiting in Cork?

76 of the 169 studies on this page are recruiting new participants as of the 21 Nov 2026, 03:15 UTC sync. A further 6 have not yet opened recruitment, 85 are active but closed to new participants, and 2 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Cork), 169 studies
PhaseStudiesRecruitingShare
Phase 3973657.4%
Not applicable291517.2%
Observational201311.8%
Phase 21247.1%
Phase 2/3553%
Phase 1/2432.4%
Phase 1100.6%
Phase 4100.6%

Most active sponsors

Lead sponsors with the most studies (Cork)
Lead sponsorStudiesRecruiting
University College Cork1811
Merck Sharp & Dohme LLC158
Cancer Trials Ireland84
AbbVie71
AstraZeneca62
Bristol-Myers Squibb43
Celgene41
Daiichi Sankyo42
Hoffmann-La Roche42
Regeneron Pharmaceuticals41
Listing here is informational and not medical advice; eligibility is determined by each study team. Patients should discuss participation with their clinician. For trials across the wider EU, see the EU Clinical Trials Tracker.